Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Safety and efficacy of nanosomal docetaxel lipid suspension (NDLS) in patients with advanced gastric adenocarcinoma.
Presenter
Vikas S. Ostwal, MD
Tata Memorial Hospital (HBNI)
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Videos & Slides Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
CTRI/2018/01/011450
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 348)
DOI
10.1200/JCO.2024.42.3_suppl.348
Abstract #
348
Poster Bd #
G9
Abstract Disclosures
Similar Videos & Slides
Speaker: Panel Discussion
Speaker: Daniel Hinshaw, MD
Videos & Slides
2024 ASCO Annual Meeting
Efficacy and safety of triplet nivolumab, relatlimab, and ipilimumab (NIVO + RELA + IPI) in advanced melanoma: Results from RELATIVITY-048.
Speaker: Paolo Antonio Ascierto, MD, BC
Videos & Slides
2024 ASCO Annual Meeting
Safety and preliminary efficacy of EIK1001 in combination with pembrolizumab in participants with advanced solid tumors.
Speaker: Anthony W. Tolcher, MD, FASCO